TT
GSK icon

TI-Trust’s GSK GSK Stock Holding History

TI-Trust’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$15K Buy
+250
New +$13.9K 0.01% 269

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

TI-Trust's GSK Position: Q4 2019 in Review

TI-Trust opened a new position in GSK (GSK) in Q4 2019: 250 shares worth $15K. The stake represents 0.01% of the portfolio and ranks #269 among its holdings.

894 funds tracked by Wall St. Rank hold GSK as of Q4 2019.

  • TI-Trust held 250 shares of GSK worth $15K as of Q4 2019.
  • GSK was a new TI-Trust position in Q4 2019.
  • GSK made up 0.01% of TI-Trust's portfolio in Q4 2019, its #269 holding.
  • 894 funds tracked by Wall St. Rank held GSK as of Q4 2019.

Based on TI-Trust's 13F filing for Q4 2019, filed 7 Feb 2020.